These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 25156222

  • 1. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Lauvsnes MB, Beyer MK, Kvaløy JT, Greve OJ, Appenzeller S, Kvivik I, Harboe E, Tjensvoll AB, Gøransson LG, Omdal R.
    Arthritis Rheumatol; 2014 Dec; 66(12):3387-94. PubMed ID: 25156222
    [Abstract] [Full Text] [Related]

  • 2. Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies.
    Lauvsnes MB, Maroni SS, Appenzeller S, Beyer MK, Greve OJ, Kvaløy JT, Harboe E, Gøransson LG, Tjensvoll AB, Omdal R.
    Arthritis Rheum; 2013 Dec; 65(12):3209-17. PubMed ID: 23982950
    [Abstract] [Full Text] [Related]

  • 3. Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies.
    Tjensvoll AB, Lauvsnes MB, Hirohata S, Beyer MK, Greve OJ, Kvivik I, Kvaløy JT, Harboe E, Gøransson LG, Omdal R.
    Eur J Neurol; 2016 Apr; 23(4):780-6. PubMed ID: 26787509
    [Abstract] [Full Text] [Related]

  • 4. Association between autoantibodies and neuropsychiatric manifestations of autoimmune disease: comment on the article by Lauvsnes et al.
    Kivity S, Shoenfeld Y.
    Arthritis Rheumatol; 2015 Jun; 67(6):1683. PubMed ID: 25709043
    [No Abstract] [Full Text] [Related]

  • 5. Reply: To PMID 25156222.
    Lauvsnes MB, Greve OJ, Kvivik I, Harboe E, Tjensvoll AB, Beyer MK, Kvaløy JT, Gøransson LG, Appenzeller S, Omdal R.
    Arthritis Rheumatol; 2015 Jun; 67(6):1683-4. PubMed ID: 25779776
    [No Abstract] [Full Text] [Related]

  • 6. Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren's syndrome: An updated meta-analysis.
    Tay SH, Fairhurst AM, Mak A.
    Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
    [Abstract] [Full Text] [Related]

  • 7. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
    Lauvsnes MB, Tjensvoll AB, Maroni SS, Kvivik I, Grimstad T, Greve OJ, Harboe E, Gøransson LG, Putterman C, Omdal R.
    Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
    [Abstract] [Full Text] [Related]

  • 8. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.
    Schwarting A, Möckel T, Lütgendorf F, Triantafyllias K, Grella S, Boedecker S, Weinmann A, Meineck M, Sommer C, Schermuly I, Fellgiebel A, Luessi F, Weinmann-Menke J.
    Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256
    [Abstract] [Full Text] [Related]

  • 9. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME, Alexander EL, Koski CL, Frank MM, Joiner KA.
    J Immunol; 1987 Apr 01; 138(7):2095-9. PubMed ID: 3559203
    [Abstract] [Full Text] [Related]

  • 10. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
    Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, Bleiberg J, Rosenstein D, Pao M, Patronas N, Steele S, Manzano M, van der Veen JW, Lipsky PE, Marenco S, Wesley R, Volpe B, Diamond B, Illei GG.
    Arthritis Rheum; 2006 Aug 01; 54(8):2505-14. PubMed ID: 16868971
    [Abstract] [Full Text] [Related]

  • 11. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG, Robichaud J, Fisk JD.
    J Rheumatol; 2006 Aug 01; 33(8):1553-8. PubMed ID: 16881112
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.
    Int J Rheum Dis; 2019 Mar 01; 22(3):443-448. PubMed ID: 30358102
    [Abstract] [Full Text] [Related]

  • 13. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A, Kiss E, Sas A, Szegedi G, Zeher M.
    Orv Hetil; 2005 Dec 11; 146(50):2533-8. PubMed ID: 16440498
    [Abstract] [Full Text] [Related]

  • 14. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M.
    Hum Immunol; 2006 Nov 11; 67(11):924-30. PubMed ID: 17145372
    [Abstract] [Full Text] [Related]

  • 15. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF, Wattiaux MJ, Van Amerongen AP.
    Encephale; 2001 Nov 11; 27(6):588-99. PubMed ID: 11865567
    [Abstract] [Full Text] [Related]

  • 16. Nailfold capillary abnormalities in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Ohtsuka T.
    Br J Dermatol; 1997 Jan 11; 136(1):94-6. PubMed ID: 9039302
    [Abstract] [Full Text] [Related]

  • 17. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE.
    J Rheumatol; 2000 Nov 11; 27(11):2617-20. PubMed ID: 11093442
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T.
    Tokai J Exp Clin Med; 1993 Dec 11; 18(3-6):133-8. PubMed ID: 7701526
    [Abstract] [Full Text] [Related]

  • 19. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y, Yanagida T, Hirohata S.
    Arthritis Rheum; 2008 Apr 11; 58(4):1130-5. PubMed ID: 18383393
    [Abstract] [Full Text] [Related]

  • 20. Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome.
    Manoussakis MN, Fragoulis GE, Vakrakou AG, Moutsopoulos HM.
    PLoS One; 2014 Apr 11; 9(11):e112100. PubMed ID: 25396412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.